ArticleRegenerative therapy2026
Low-frequency electromagnetic fields ameliorate testosterone-induced androgenetic alopecia in mice through LncRNA H19/miR-214-5p/β-catenin signal pathway.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In androgenetic alopecia (AGA), the depletion or long-term inactivity of the hair follicle stem cells (HFSCs) pool is a fundamental cause. Reviving inactive HFSCs is regarded as a promising treatment method for hair loss. Objective: This study explored whether applying low-frequency electromagnetic fields (LFEMF) (1 Hz and 50 Hz) externally can enhance the activation and proliferation of HFSCs and alleviate symptoms of AGA in mice via the LncRNA H19/miR-214-5p/β-catenin signal pathway. Methods: Scalp samples were obtained from 30 AGA patients and 30 healthy controls. The levels of LncRNA H19, miR-214-5p and β-catenin were assessed using qRT-PCR and Western blotting. Male C57BL/6 mice were employed to generate a dihydrotestosterone (DHT)-induced AGA model, while HFSCs were served to construct a DHT-induced in vitro cellular model. Subsequently, the effects and underlying mechanisms of LFEMFs treatment were examined through immunohistochemistry, direct observation of hair growth, cell proliferation assays, cell cycle and apoptosis analysis, as well as qRT-PCR and Western blotting. The relationship between LncRNA H19, miR-214-5p and β-catenin were further explored using RNA pull-down, RNA-binding protein immunoprecipitation (RIP), fluorescence in situ hybridization (FISH), and luciferase reporter assay. Results: LFEMF stimulated hair regeneration in mice and reversed DHT-induced cell apoptosis by activating LncRNA H19/miR-214-5p/β-catenin signaling pathway. Conclusion: LFEMF alleviates DHT-induced AGA and stimulates hair regrowth in mice by activating Wnt/β-catenin signaling pathway, suggesting its potential as a therapeutic strategy for AGA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.